Legacy Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$640K Buy
696
+100
+17% +$101K 0.33% 39
2025
Q4
$641K Buy
+596
New +$570K 0.42% 34

Other funds holding LLY

Legacy Wealth Advisors's LLY Position: Q1 2026 in Review

Legacy Wealth Advisors increased its Eli Lilly (LLY) stake by 17% in Q1 2026, buying an estimated $101K and bringing the position to 696 shares worth $640K. The position accounts for 0.33% of the portfolio, ranked #39.

Legacy Wealth Advisors first reported a position in LLY in Q4 2025 and has held it in 2 quarters since. The position peaked at $641K in Q4 2025. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Legacy Wealth Advisors held 696 shares of Eli Lilly worth $640K as of Q1 2026.
  • Legacy Wealth Advisors bought 100 Eli Lilly shares in Q1 2026, an estimated $101K.
  • Eli Lilly made up 0.33% of Legacy Wealth Advisors's portfolio in Q1 2026, its #39 holding.
  • Legacy Wealth Advisors first reported a position in Eli Lilly in Q4 2025 and has held it in 2 quarters since.
  • Legacy Wealth Advisors's Eli Lilly position peaked at $641K in Q4 2025.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Legacy Wealth Advisors's 13F filing for Q1 2026, filed 6 May 2026.